Advanced Anti-Wrinkle Therapy Cicatricure

AVOBENXONE 3%, OCTINOXATE 7.5%, OCTISALATE 5%, OCTOCRYLENE 2.7%, OXYBENZONE 4% TOPICAL HUMAN OTC DRUG

Advanced Anti-Wrinkle Therapy Cicatricure is an FDA drug label for the active ingredient AVOBENXONE 3%, OCTINOXATE 7.5%, OCTISALATE 5%, OCTOCRYLENE 2.7%, OXYBENZONE 4% manufactured by Genomma Lab administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20190218.

Generic name: AVOBENXONE 3%, OCTINOXATE 7.5%, OCTISALATE 5%, OCTOCRYLENE 2.7%, OXYBENZONE 4%
Manufacturer: Genomma Lab
Product type: HUMAN OTC DRUG
Route: TOPICAL
Dosage form: N/A
NDC: 50066-021
Application: part352
Label effective: 20190218

Active ingredients

Avobenzone 3%., Octinoxate 7.5%, Octisalate 5%,Octocrylene 2.7%,Oxybenzone 4%.

Indications & Usage

Uses • helps prevent sunburn • if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Dosage & Administration

Directions For sunscreen use : • apply generously and evenly 15 minutes before sun exposure. Reapply at least every 2 hours • use a water resistant sunscreen if swimming or sweating. Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF factor of 15 or higher and other skin protection measures including: • limit time in the sun, especially from 10am to 2pm • wear long-sleeved shirts, pants, hats and sunglasses • children under 6 months of age: ask a doctor

Contraindications

Not available.

Warnings

Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs.

Adverse Reactions

Not available.